Loading...
Targeting β-amyloid pathology in Alzheimer’s disease with Aβ immunotherapy
More than 10 clinical trials of Aβ immunotherapy are currently underway in patients with Alzheimer’s disease (AD). The aim is to identify safe approaches for the efficacious antibody-mediated removal of brain β-amyloid or its neurotoxic oligomeric precursors consisting of aggregated amyloid β-peptid...
Na minha lista:
| Udgivet i: | Neurotherapeutics |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Springer-Verlag
2008
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5084243/ https://ncbi.nlm.nih.gov/pubmed/18625453 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurt.2008.05.013 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|